Tailored chemo dosing aims to boost cancer fight, cut side effects
NCT ID NCT06501989
Summary
This study aimed to see if adjusting the dose of a standard chemotherapy drug (5-FU) based on its level in a patient's blood could improve treatment for metastatic colorectal cancer. It planned to test this personalized dosing approach in adults newly diagnosed with advanced colon cancer that had spread. The goal was to find the most effective dose for each person while trying to reduce severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Health Care Service
Falls Church, Virginia, 22042, United States
Conditions
Explore the condition pages connected to this study.